Comparative effectiveness and cost-effectiveness of target- versus benefit-based treatment of type 2 diabetes in low- and middle-income countries
39 citations
FWCI 31.42
Health Systems, Economic Evaluations, Quality of Life
Trend
Citation data as of 2026-04-12 (OpenAlex).
Extracted findings
This paper hasn't been extracted into the knowledge graph yet. We're working through the corpus — 5315061 is in the queue.